168 related articles for article (PubMed ID: 27980217)
1. The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets.
Sun S; Cai J; Yang Q; Zhao S; Wang Z
Oncotarget; 2017 Feb; 8(9):16036-16051. PubMed ID: 27980217
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer.
Li T; Peng J; Zeng F; Zhang K; Liu J; Li X; Ouyang Q; Wang G; Wang L; Liu Z; Liu Y
Int J Clin Pharmacol Ther; 2017 Oct; 55(10):774-780. PubMed ID: 28737129
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
4. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.
Blair BG; Larson CA; Safaei R; Howell SB
Clin Cancer Res; 2009 Jul; 15(13):4312-21. PubMed ID: 19509135
[TBL] [Abstract][Full Text] [Related]
5. Association of copper transporter expression with platinum resistance in epithelial ovarian cancer.
Yoshida H; Teramae M; Yamauchi M; Fukuda T; Yasui T; Sumi T; Honda K; Ishiko O
Anticancer Res; 2013 Apr; 33(4):1409-14. PubMed ID: 23564780
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.
Ip V; Liu JJ; Mercer JF; McKeage MJ
Mol Pain; 2010 Sep; 6():53. PubMed ID: 20836889
[TBL] [Abstract][Full Text] [Related]
7. Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin.
Huang CP; Fofana M; Chan J; Chang CJ; Howell SB
Metallomics; 2014 Mar; 6(3):654-61. PubMed ID: 24522273
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of organic anion transporting polypeptide 1B3 and copper transporter 1 expression in endometrial cancer patients treated with paclitaxel and carboplatin.
Ogane N; Yasuda M; Kameda Y; Yokose T; Kato H; Itoh A; Nishino S; Hashimoto Y; Kamoshida S
Biomed Res; 2013 Jun; 34(3):143-51. PubMed ID: 23782748
[TBL] [Abstract][Full Text] [Related]
9. The role of Ctr1 and Ctr2 in mammalian copper homeostasis and platinum-based chemotherapy.
Öhrvik H; Thiele DJ
J Trace Elem Med Biol; 2015; 31():178-82. PubMed ID: 24703712
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy.
Lee YY; Choi CH; Do IG; Song SY; Lee W; Park HS; Song TJ; Kim MK; Kim TJ; Lee JW; Bae DS; Kim BG
Gynecol Oncol; 2011 Aug; 122(2):361-5. PubMed ID: 21570711
[TBL] [Abstract][Full Text] [Related]
11. The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease.
Wee NK; Weinstein DC; Fraser ST; Assinder SJ
Int J Biochem Cell Biol; 2013 May; 45(5):960-3. PubMed ID: 23391749
[TBL] [Abstract][Full Text] [Related]
12. Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin.
Matsumoto S; Tanaka T; Kurokawa H; Matsuno K; Hayashida Y; Takahashi T
Anticancer Res; 2007; 27(4B):2209-16. PubMed ID: 17695505
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
Ip V; Liu JJ; McKeage MJ
Clin Exp Pharmacol Physiol; 2013 Jun; 40(6):371-8. PubMed ID: 23556474
[TBL] [Abstract][Full Text] [Related]
14. Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy.
Chen HH; Yan JJ; Chen WC; Kuo MT; Lai YH; Lai WW; Liu HS; Su WC
Lung Cancer; 2012 Feb; 75(2):228-34. PubMed ID: 21788094
[TBL] [Abstract][Full Text] [Related]
15. Gene duplication and neo-functionalization in the evolutionary and functional divergence of the metazoan copper transporters Ctr1 and Ctr2.
Logeman BL; Wood LK; Lee J; Thiele DJ
J Biol Chem; 2017 Jul; 292(27):11531-11546. PubMed ID: 28507097
[TBL] [Abstract][Full Text] [Related]
16. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin.
Miyashita H; Nitta Y; Mori S; Kanzaki A; Nakayama K; Terada K; Sugiyama T; Kawamura H; Sato A; Morikawa H; Motegi K; Takebayashi Y
Oral Oncol; 2003 Feb; 39(2):157-62. PubMed ID: 12509969
[TBL] [Abstract][Full Text] [Related]
17. Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.
Kim ES; Tang X; Peterson DR; Kilari D; Chow CW; Fujimoto J; Kalhor N; Swisher SG; Stewart DJ; Wistuba II; Siddik ZH
Lung Cancer; 2014 Jul; 85(1):88-93. PubMed ID: 24792335
[TBL] [Abstract][Full Text] [Related]
18. Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells.
Akerfeldt MC; Tran CM; Shen C; Hambley TW; New EJ
J Biol Inorg Chem; 2017 Jul; 22(5):765-774. PubMed ID: 28516214
[TBL] [Abstract][Full Text] [Related]
19. Expression of copper-transporting P-type adenosine triphosphatase in human esophageal carcinoma.
Higashimoto M; Kanzaki A; Shimakawa T; Konno S; Naritaka Y; Nitta Y; Mori S; Shirata S; Yoshida A; Terada K; Sugiyama T; Ogawa K; Takebayashi Y
Int J Mol Med; 2003 Mar; 11(3):337-41. PubMed ID: 12579336
[TBL] [Abstract][Full Text] [Related]
20. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells.
Blair BG; Larson CA; Adams PL; Abada PB; Safaei R; Howell SB
Mol Pharmacol; 2010 Jun; 77(6):912-21. PubMed ID: 20194531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
